Pfizer Profit Falls Amid Lower Covid-19 Drug Demand

Core Viewpoint - Pfizer reported a decline in third-quarter profit due to decreasing demand for its Covid-19 vaccine and antiviral drug [1] Financial Performance - The company experienced lower profits in the third quarter compared to previous periods, indicating a significant impact from reduced sales of Covid-19 related products [1] Market Demand - There is a continuing decline in demand for both the Covid-19 vaccine and antiviral treatments, which has been a major revenue source for Pfizer [1]